Recent Updates
Recently added Catalysts
LEGN Positive Sentiment Score: 70/100

Voting Results of 2024 Annual General Meeting At Legend Biotech Corporation s (the Company ) annual general meeting of shareholders held on

Monday, October 21, 2024 1 min read
Key Takeaway: Legend Biotech Corporation held its 2024 Annual General Meeting on October 21, 2024, with 95.3% of outstanding shares represented. Shareholders overwhelmingly supported the reception of the audited financial statements and the appointment of Ernst & Young LLP as independent auditor for the fiscal year. Elections for directors also saw considerable backing, with the majority of candidates receiving over 90% of the votes in favor. The meeting reflected strong shareholder engagement and confidence in the company's governance.

Market Sentiment Analysis

POSITIVE FACTORS

  • High shareholder turnout at the AGM with 95.3% of shares represented.
  • Strong support for resolutions with over 95% in favor of financial statement reception and auditor ratification.
  • Successful election of most directors with significant majority votes.

Full Press Release Details

Voting Results of 2024 Annual General Meeting
At Legend Biotech Corporation s (the Company ) annual general meeting of shareholders held on October 21, 2024 (the AGM ), the
Company s shareholders:
A total of approximately
351,102,656 ordinary shares, including those underlying ADSs, representing approximately 95.3% of the ordinary shares issued and outstanding as of September 17, 2024, the record date, were present in person or by proxy at the AGM. The results
of the votes are as follows:
For Against Abstain
Resolutions Votes % Votes % Votes %
Reception of Audited Financial Statements 351,026,682 95.238 % 35,060 0.010 % 40,914 0.011 %
Ratification of appointment of Ernst & Young LLP as Independent Auditor for Fiscal Year 2024 351,070,748 95.250 % 3,276 0.001 % 28,632 0.008 %
Election of Directors
Ye Wang (Class I) 254,083,338 68.936 % 96,987,136 26.314 % 32,182 0.009 %
Dr. Darren Xiahui Ji (Class I) 344,087,858 93.356 % 6,982,614 1.894 % 32,184 0.009 %
Dr. Ying Huang (Class I) 350,256,394 95.029 % 814,082 0.221 % 32,180 0.009 %
Tomas Heyman (Class I) 344,761,778 93.539 % 6,307,538 1.711 % 33,340 0.009 %
Amendment and Restatement of 2020 Restricted Shares Plan 347,474,014 94.275 % 3,601,752 0.977 % 26,890 0.007 %
Authorization of Directors and Officers 350,780,616 95.172 % 191,268 0.052 % 130,772 0.035 %

Frequently Asked Questions

What percentage of shares were represented at the AGM?

Approximately 95.3% of ordinary shares were represented at the AGM.

Who was appointed as the Independent Auditor for 2024?

Ernst & Young LLP was ratified as the Independent Auditor for Fiscal Year 2024.

What was the vote outcome for Dr. Ying Huang's election?

Dr. Ying Huang received 95.029% approval for election to the board.

How many votes were cast for the amendment of the Restricted Shares Plan?

The amendment and restatement received 94.275% approval from voting shareholders.

What was the result of the authorization of Directors and Officers?

The resolution received 95.172% approval from shareholders at the AGM.

Tags: LEGN Viatris Investor Conferences Healthcare Legend Biotech AGM shareholder voting 2024 results
Last updated: Oct 21, 2024